Actions

Newsfeed Popular Local Discover Follows Blocks Bookmarks Filters Settings PowerUps Help Updates

prnewswire.com / Share Newsitem

View, share or embed this newsitem using the details below.

PR Newswire: press release distribution, targeting, monitoring and marketing

@prnewswire.com/20 hours20h

FDA Approves First Generic of Once-Daily GLP-1 Injection to Lower Blood Sugar in Patients with Type 2 Diabetes

/PRNewswire/ -- Today, the U.S. Food and Drug Administration approved the first generic referencing Victoza (liraglutide injection) 18 milligram/3 milliliter,

https://newsreadery.com/go/ad9d7bf02ece394734b7631588d468f9

Save

Back

Read Full Article